ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
70,235
0,00%
Bitcoin
82 145,99
-4,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Amneal Pharmaceuticals Inc (AMRX) Cours

Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc (AMRX)

NASDAQ
8,90
0,14
(1,60%)
Fermé 09 Mars 9:00PM
Retardé de 15 minutes
8,96
0,06
(0,67%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
8,90
Prix Achat
8,43
Prix Vente
9,00
Volume échangé
2 274 898
8,56 Fourchette du Jour 8,995
5,18 Plage de 52 semaines 9,475
Cap du marché
2,758B
Clôture Veille
8,76
Ouverture
8,73
Dernière Transaction
1
@
8.89
Dernière heure de transaction
Volume financier
US$ 20 015 812
VWAP
8,7986
Volume moyen (3 m)
1 317 349
Actions en circulation
309 844 430
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-21,65
Bénéfice par action (BPA)
-0,27
Chiffre d'affairess
2,41B
Bénéfice net
-83,99M

À propos de Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.amneal.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Amneal Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AMRX. Le dernier cours de clôture d'Amneal Pharmaceuticals était de US$8,76. Au cours de la dernière année, les actions de Amneal Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 5,18 à US$ 9,475.

Amneal Pharmaceuticals compte actuellement 309 844 430 actions en circulation. La capitalisation boursière d'Amneal Pharmaceuticals est de US$2,71 milliard. Amneal Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -21.65.

AMRX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Mars 2025
AMRX (1,60%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
05 Mars 2025
AMRX (1,60%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
05 Mars 2025
AMRX (1,60%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
AMRX (1,60%)

Form 8-K - Current report
Edgar (US Regulatory)
28 Février 2025
AMRX (1,60%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.9411.80904522617.969.167.6124144568.78996874CS
41.0112.80101394177.899.167.6116449878.39916579CS
120.9812.37373737377.929.167.5713173498.21905352CS
260.516.078665077478.399.4757.5211861498.3926747CS
523.667.92452830195.39.4755.1813218537.46957022CS
1563.0251.36054421775.889.4755.0113457797.14291663CS
2603.0251.36054421775.889.4755.0113457797.14291663CS

AMRX - Frequently Asked Questions (FAQ)

What is the current Amneal Pharmaceuticals share price?
The current share price of Amneal Pharmaceuticals is US$ 8,90
How many Amneal Pharmaceuticals shares are in issue?
Amneal Pharmaceuticals has 309 844 430 shares in issue
What is the market cap of Amneal Pharmaceuticals?
The market capitalisation of Amneal Pharmaceuticals is USD 2,71B
What is the 1 year trading range for Amneal Pharmaceuticals share price?
Amneal Pharmaceuticals has traded in the range of US$ 5,18 to US$ 9,475 during the past year
What is the PE ratio of Amneal Pharmaceuticals?
The price to earnings ratio of Amneal Pharmaceuticals is -21,65
What is the cash to sales ratio of Amneal Pharmaceuticals?
The cash to sales ratio of Amneal Pharmaceuticals is 0,75
What is the reporting currency for Amneal Pharmaceuticals?
Amneal Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Amneal Pharmaceuticals?
The latest annual turnover of Amneal Pharmaceuticals is USD 2,41B
What is the latest annual profit for Amneal Pharmaceuticals?
The latest annual profit of Amneal Pharmaceuticals is USD -83,99M
What is the registered address of Amneal Pharmaceuticals?
The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Amneal Pharmaceuticals website address?
The website address for Amneal Pharmaceuticals is www.amneal.com
Which industry sector does Amneal Pharmaceuticals operate in?
Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPSCapstone Holding Corp
US$ 3,50
(1 300,00%)
36,33k
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,13M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
476,73M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
618,03M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,77M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
AMRX
Amneal Pharmaceuticals
LSE
BQ00
Platform Mtg 32
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces